Australia is one of few countries in the the world to allow psychedelic-assisted therapy to treat specific types of mental illness, under strict conditions. But use of the therapy, approved by the Therapeutic Goods Administration last year, has so far been very limited and more research is needed to understand the potential benefits and long-term effects. One study, by Monash University, is considering if psylocibin [[SY-luh-SY-bin]] - a compound found in magic mushrooms - can be effective in treating anxiety.